Quantitative CT Imaging-Based Characteristics In Asthma And COPD Populations With Chronic Functional Alterations

E A Hoffman; J D Newell; S E Wenzel; M Castro; S B Fain; N N Jarjour; M Schiebler; R G Barr; M K Han; C B Cooper; D Couper; N N Hansel; R E Kanner; E Kazerooni; E Kleerup; W O'Neal; P G Woodruff; F J Martinez; S Choi; E Bleecker; B Haghighi; C L Lin

Back

Quantitative CT Imaging-Based Characteristics In Asthma And COPD Populations With Chronic Functional Alterations

Abstract

Peer reviewed

Quantitative CT Imaging-Based Characteristics In Asthma And COPD Populations With Chronic Functional Alterations

E A Hoffman, J D Newell, S E Wenzel, M Castro, S B Fain, N N Jarjour, M Schiebler, R G Barr, M K Han, C B Cooper, …

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol.195, A4870

Annual American Thoracic Society Meeting (Washington, DC, USA)

2017

View Online

Details

Title: Subtitle: Quantitative CT Imaging-Based Characteristics In Asthma And COPD Populations With Chronic Functional Alterations
Creators: E A Hoffman
J D Newell
S E Wenzel
M Castro
S B Fain
N N Jarjour
M Schiebler
R G Barr
M K Han
C B Cooper
D Couper
N N Hansel
R E Kanner
E Kazerooni
E Kleerup
W O'Neal
P G Woodruff
F J Martinez
S Choi
E Bleecker
B Haghighi
C L Lin
Resource Type: Abstract
Publication Details: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol.195, A4870
Conference: Annual American Thoracic Society Meeting (Washington, DC, USA)
Publisher: American Thoracic Society
ISSN: 1535-4970
Grant note: This abstract is funded by: NIH grants U01 HL114494, HL209152; R01 HL094315, HL112986, HL69174, HL064368, HL091762, HL069116; S10RR022421; U10 HL109257, HL109168; UL1 RR024153 (CTSI), UL1 TR000448, UL1 TR000427 (CTSA). The Subpopulations and IntermediateOutcomes in COPD Study (SPIROMICS) was supported by contracts from the NIH/NHLBI (HHSN268200900013C, HHSN268200900014C,HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C,HHSN268200900020C), which were supplemented by contributions made through the Foundation for the NIH from AstraZeneca;Bellerophon Therapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc; Chiesi Farmaceutici SpA; Forest Research Institute, Inc; GSK; GrifolsTherapeutics, Inc; Ikaria, Inc; Nycomed GmbH; Takeda Pharmaceutical Company; Novartis Pharmaceuticals Corporation; RegeneronPharmaceuticals, Inc; and Sanofi.
Language: English
Date published: 2017
Academic Unit: Electrical and Computer Engineering; Roy J. Carver Department of Biomedical Engineering; Mechanical Engineering; Internal Medicine; Radiology
Record Identifier: 9984231831102771

Metrics

15 Record Views